Understanding of Cutaneous Neurofibromas Award
Neurofibromatosis Therapeutic Acceleration Program (NTAP) launched a new research program focused on understanding the pathogenesis of cutaneous neurofibromas. NTAP is a philanthropic research entity based at Johns Hopkins University dedicated to the discovery of therapeutics for the peripheral nerve tumors that afflict people with neurofibromatosis type 1 (NF1). This research program sets the blueprint for improving therapeutics for these tumors by encouraging research proposals that improve the understanding of cutaneous neurofibromas.
Letters of intent are due by May 12, 2017. Applicants will be notified by May 31, 2017 if they are invited to submit a full proposal. The request for applications includes detailed application instructions.
For more information, contact Dr. Sharad Verma at firstname.lastname@example.org, or Dr. Jaishri Blakeley at email@example.com.
Request for Applications